Addressing Disparities in Diabetes Care: Integrating Continuous Glucose Monitors and Pharmacist Medication Management for Uninsured Racial Minority Patients
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 20
- Locations
- 2
- Primary Endpoint
- Change in Hemoglobin A1c
Study Overview
Brief Summary
The purpose of this research is to find out if using a continuous glucose monitor and working with a clinical pharmacist can help improve the health of uninsured minority patients with type 2 diabetes.
Detailed Description
The objective of this research is to determine the effectiveness of a targeted intervention that integrates continuous glucose monitors and pharmacist-led comprehensive medication management services among uninsured adult patients with poor glycemic control on basal insulin, specifically focusing on Black and Hispanic populations. This pilot study is designed to help justify implementing this intervention on a larger scale within our healthcare system.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Supportive Care
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Hispanic or non-Hispanic Black
- •Diagnosis of Type 2 diabetes
- •HbA1c ≥8% within the past 3 months
- •Active prescription for insulin and injecting at least 1 time daily
Exclusion Criteria
- •Gestational diabetes
- •Type 1 diabetes
- •Receiving care by endocrinologist
- •Continuous glucose monitor use within the past 6 months
- •Receiving long term, hospice, or palliative care services
- •Malignant cancer
Outcomes
Primary Outcomes
Change in Hemoglobin A1c
Time Frame: Baseline to Month 6
Change in percentage for Hemoglobin A1c. Normal range for hemoglobin A1c is 4.2%-14%. A low level indicates no diabetes and a high level indicates uncontrolled diabetes.
Secondary Outcomes
- Appraisal of Diabetes Scale(Baseline, 1 Month Post Intervention)
- Diabetes Treatment Satisfaction Questionnaire(Baseline, 1 Month Post Intervention)
- Change in Medication Adherence(6 Months Post Intervention)
- Number of Hours Glucose Level in Normal Range(Week 1 and 2 of intervention, Last Two Weeks of Intervention)
- Number of Hours Glucose Level Above Normal Range(Week 1 and 2 of intervention, Last Two Weeks of Intervention)
- Number of Hours Glucose Level Below Normal Range(Week 1 and 2 of intervention, Last Two Weeks of Intervention)
- Average Glucose Level(Week 1 and 2 of intervention, Last Two Weeks of Intervention)
- Glucose Management Indicator Percentage(Week 1 and 2 of intervention, Last Two Weeks of Intervention)
- Change in Medication Adherence(6 Months Post Intervention)